Drug intelligence / Profile preview

Curvit

Development stage: Unknown
Lead developer: SoHo Capital
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Curvit is a natural multivitamin and appetite stimulant supplement developed and manufactured by Soho Global Health (PT Soho Industri Pharmasi) in Indonesia. It is formulated to improve appetite, support stamina, and prevent calcium deficiency in both children and adults. The supplement contains a synergistic blend of curcuminoids (extracted from *Curcuma xanthorrhiza* or temulawak), calcium gluconate, and essential vitamins including vitamin B-complex (B1, B2, B6, B12), beta-carotene, and dexpanthenol. Curvit is available in various oral formulations, including syrup, emulsion, and film-coated caplets.

Brand names: CurvitCurvit CL EmulsionCurvit FCTCurvit KapletCurvit Sirup

Beyond the preview

Go deeper on Curvit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curvit.

Explore the full profile